Scientists link common immune cell to failure of checkpoint inhibitors in lung cancer — SCIENMAG

The study published in JCI Insight suggests how to better predict which patients will respond to immunotherapyCredit: Fred Hutchinson Cancer Research Center For many lung cancer patients, the best treatment options involve checkpoint inhibitors. These drugs unleash a patient’s immune system against their disease and can yield dramatic results, even in advanced cancers. But checkpoint…

Read the full article here

Related Articles